BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 32687484)

  • 1. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.
    Remy KE; Mazer M; Striker DA; Ellebedy AH; Walton AH; Unsinger J; Blood TM; Mudd PA; Yi DJ; Mannion DA; Osborne DF; Martin RS; Anand NJ; Bosanquet JP; Blood J; Drewry AM; Caldwell CC; Turnbull IR; Brakenridge SC; Moldwawer LL; Hotchkiss RS
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32687484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
    Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
    Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
    [No Abstract]   [Full Text] [Related]  

  • 3. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease.
    Zhao Y; Qin L; Zhang P; Li K; Liang L; Sun J; Xu B; Dai Y; Li X; Zhang C; Peng Y; Feng Y; Li A; Hu Z; Xiang H; Ogg G; Ho LP; McMichael A; Jin R; Knight JC; Dong T; Zhang Y
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32501293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
    Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a "Cytokine Storm" Relevant to COVID-19?
    Sinha P; Matthay MA; Calfee CS
    JAMA Intern Med; 2020 Sep; 180(9):1152-1154. PubMed ID: 32602883
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection.
    Copaescu A; Smibert O; Gibson A; Phillips EJ; Trubiano JA
    J Allergy Clin Immunol; 2020 Sep; 146(3):518-534.e1. PubMed ID: 32896310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
    Bhaskar S; Sinha A; Banach M; Mittoo S; Weissert R; Kass JS; Rajagopal S; Pai AR; Kutty S
    Front Immunol; 2020; 11():1648. PubMed ID: 32754159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
    Hadjadj J; Yatim N; Barnabei L; Corneau A; Boussier J; Smith N; Péré H; Charbit B; Bondet V; Chenevier-Gobeaux C; Breillat P; Carlier N; Gauzit R; Morbieu C; Pène F; Marin N; Roche N; Szwebel TA; Merkling SH; Treluyer JM; Veyer D; Mouthon L; Blanc C; Tharaux PL; Rozenberg F; Fischer A; Duffy D; Rieux-Laucat F; Kernéis S; Terrier B
    Science; 2020 Aug; 369(6504):718-724. PubMed ID: 32661059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
    Wang J; Jiang M; Chen X; Montaner LJ
    J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 infection: the perspectives on immune responses.
    Shi Y; Wang Y; Shao C; Huang J; Gan J; Huang X; Bucci E; Piacentini M; Ippolito G; Melino G
    Cell Death Differ; 2020 May; 27(5):1451-1454. PubMed ID: 32205856
    [No Abstract]   [Full Text] [Related]  

  • 15. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The many faces of the anti-COVID immune response.
    Vardhana SA; Wolchok JD
    J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32353870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.
    De Biasi S; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Gozzi L; Iannone A; Lo Tartaro D; Mattioli M; Paolini A; Menozzi M; Milić J; Franceschi G; Fantini R; Tonelli R; Sita M; Sarti M; Trenti T; Brugioni L; Cicchetti L; Facchinetti F; Pietrangelo A; Clini E; Girardis M; Guaraldi G; Mussini C; Cossarizza A
    Nat Commun; 2020 Jul; 11(1):3434. PubMed ID: 32632085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the Inflammatory Response to Severe COVID-19 Illness.
    McElvaney OJ; McEvoy NL; McElvaney OF; Carroll TP; Murphy MP; Dunlea DM; Ní Choileáin O; Clarke J; O'Connor E; Hogan G; Ryan D; Sulaiman I; Gunaratnam C; Branagan P; O'Brien ME; Morgan RK; Costello RW; Hurley K; Walsh S; de Barra E; McNally C; McConkey S; Boland F; Galvin S; Kiernan F; O'Rourke J; Dwyer R; Power M; Geoghegan P; Larkin C; O'Leary RA; Freeman J; Gaffney A; Marsh B; Curley GF; McElvaney NG
    Am J Respir Crit Care Med; 2020 Sep; 202(6):812-821. PubMed ID: 32584597
    [No Abstract]   [Full Text] [Related]  

  • 19. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.